Search bioRxiv⌕ Search

Biology subjects

Berardelli, S.

Publications and source records attributed to Berardelli, S..

3 recordsLinked to original sources

Benchmarking generative AI tools for literature retrieval and summarization in genomic variant interpretation.

BackgroundGenerative AI is increasingly used to extract structured information across domains, but its reliability in academic and clinical research, where precision and accuracy are essential, remains largely unexplored. This study evaluates the ability of Large Language Models (LLMs)-based algorithms to generate accurate, literature-based summaries of human genomic variants, with a focus on real-world usability. ResultsWe benchmarked five open-access generative AI platforms--ChatGPT, MistralAI, VarChat, Perplexity, and ScholarAI--across 40 curated variants equally divided between somatic and germline settings. For each variant, summary reports were generated and blindly evaluated by domain experts using five defined metrics. VarChat emerged as the top-ranked tool, showing the highest summarization accuracy, citation relevance, and robustness against hallucinations. Gpt-4o consistently ranked second, showing particularly stable robustness in conditions where the literature was scarce. Perplexity and ScholarAI, despite being literature-focused, ranked lowest across most metrics. Tool performance was strongly influenced by the availability of peer-reviewed literature, confirming that current generative models remain sensitive to data scarcity. ConclusionsOur findings highlight the heterogeneity of current generative AI tools in genomic variant interpretation workflows. While some platforms already provide useful outputs, reliable integration into basic and clinical research requires expert validation and domain-related fine-tuning. This work provides for the first time a curated benchmark for assessing LLM-generated content in variant genomics and underscores the need for caution when using these tools to support variant interpretation.

bioinformatics↗

Evaluation of enzyme activity predictions for variants of unknown significance in Arylsulfatase A

Continued advances in variant effect prediction are necessary to demonstrate the ability of machine learning methods to accurately determine the clinical impact of variants of unknown significance (VUS). Towards this goal, the ARSA Critical Assessment of Genome Interpretation (CAGI) challenge was designed to characterize progress by utilizing 219 experimentally assayed missense VUS in the Arylsulfa-tase A (ARSA) gene to assess the performance of community-submitted predictions of variant functional effects. The challenge involved 15 teams, and evaluated additional predictions from established and recently released models. Notably, a model developed by participants of a genetics and coding bootcamp, trained with standard machine-learning tools in Python, demonstrated superior performance among sub-missions. Furthermore, the study observed that state-of-the-art deep learning methods provided small but statistically significant improvement in predictive performance compared to less elaborate techniques. These findings underscore the utility of variant effect prediction, and the potential for models trained with modest resources to accurately classify VUS in genetic and clinical research.

genetics↗

Digenic variant interpretation with hypothesis-driven explainable AI

MotivationThe digenic inheritance hypothesis holds the potential to enhance diagnostic yield in rare diseases. Computational approaches capable of accurately interpreting and prioritizing digenic combinations based on the probands phenotypic profiles and familial information can provide valuable assistance to clinicians during the diagnostic process. ResultsWe have developed diVas, a hypothesis-driven machine learning approach that can effectively interpret genomic variants across different gene pairs. DiVas demonstrates strong performance both in classifying and prioritizing causative pairs, consistently placing them within the top positions across 11 real cases (achieving 73% sensitivity and a median ranking of 3). Additionally, diVas exploits Explainable Artificial Intelligence (XAI) to dissect the digenic disease mechanism for predicted positive pairs. Availability and ImplementationPrediction results of the diVas method on a high-confidence, comprehensive, manually curated dataset of known digenic combinations are available at oliver.engenome.com.

bioinformatics↗